Scientific Program

Thursday 14th September

09h00 : Welcome and registration

09h30 : Tutorial Lectures - Pr Patrick Dallemagne  (University of Caen, France)

Développement de principes actifs pléiotropes (MTDL) : le cas du donécopride

10h30 : Rounde-Table

11h00 : Coffee-break

11h30 : Oral communication 1

11h50 : Oral communication 2

12h10 : Oral communication 3

12h30 : lunch

13h30 : Poster session 1

14h20 : Plenary session 1- Pr. Yves Janin  (Institut Pasteur, France)

From new chemical entities to antivirals, to human dihydroorotate dehydrogenase inhibitors

15h00 : Oral communication 4

15h20 : Oral communication 5

15h40 : Oral communication 6

16h00 : Coffee-break 1

16h30 : Plenary session 2- Dr. Judith E. Unterlass (Karolinska Institutet, Sweden)

Structural insights into human PHGDH - a promising target for cancer treatment

17h30 : Social Event

19h00 : Gala dinner

Friday 15th September

09h00 : Plenary session 3Pr Pr Anna Hirsch (Saarland University , Germany)

Exploring hit identification strategies for the energy - coupling factor transporters: towards novel antibiotics

09h50 : Oral communication 7

10h10 : Oral communication 8

10h30 : Coffee-break

10h50 : Poster session 2

 

11h30 : Plenary session 4 - Dr. Hamid Hoveyda (Ogeda, formerly Euroscreen, Belgium) 

Discovery of Fezolinetant : A Record Success Story in the Wallonia Biotech

12h20: Award Ceremony

12h40 : lunch

14h00 : Meeting of the « Groupe de Contact FNRS Chimie médicinale »

15h00 : End of the congress